| ARTHREX-GMBH |
ARTHREX-GMBH |
62%
|
of coverage, including filing newer, more targeted patent applications as older patents near expiration. Manufacturing and Supply We do not own or operate manufacturing facilities for the production … |
| BAX |
Baxter International Inc. |
62%
|
Reciprocal relationship from BAX graph: Reciprocal relationship from RGNT graph: of coverage, including filing newer, more targeted patent applications as older patents near expiration. Manufacturing… |
| BAXTER-HEALTHCARE-CORPORATION |
BAXTER-HEALTHCARE-CORPORATION |
62%
|
of coverage, including filing newer, more targeted patent applications as older patents near expiration. Manufacturing and Supply We do not own or operate manufacturing facilities for the production … |
| B-BUSINESS-OVERVIEW-REGENTIS-BIOMATERIALS-LTD |
B-BUSINESS-OVERVIEW-REGENTIS-BIOMATERIALS-LTD |
62%
|
sses. For example, our Chairman and Chief Executive Officer is employed by Medica Venture Partners. If our directors’ and other officers’ other business affairs require them to devote substantial amo… |
| ISTO-TECHNOLOGIES-INC |
ISTO-TECHNOLOGIES-INC |
62%
|
of coverage, including filing newer, more targeted patent applications as older patents near expiration. Manufacturing and Supply We do not own or operate manufacturing facilities for the production … |
| LEGAL-PROCEEDINGS-CSL-BEHRING-GMBH |
LEGAL-PROCEEDINGS-CSL-BEHRING-GMBH |
62%
|
courts and government agencies. Due to the rapidly changing nature of these data privacy laws, there is not always clear guidance from the respective governments and regulators regarding the interpre… |
| MARKETING-LTD |
MARKETING-LTD |
62%
|
of coverage, including filing newer, more targeted patent applications as older patents near expiration. Manufacturing and Supply We do not own or operate manufacturing facilities for the production … |
| MEDICA-VENTURE-PARTNERS |
MEDICA-VENTURE-PARTNERS |
62%
|
sses. For example, our Chairman and Chief Executive Officer is employed by Medica Venture Partners. If our directors’ and other officers’ other business affairs require them to devote substantial amo… |
| OCEANTECH-CORP |
OCEANTECH-CORP |
62%
|
expenses, net (331 ) 1,644 (806 ) General and administrative expenses (6,637 ) (712 ) (1,125 ) Operating profit (loss) (6,968 ) 932 (1,931 ) Financial income (expense), net: Changes in fair value of … |
| WHILE-VERICEL-ARTHREX-GMBH |
WHILE-VERICEL-ARTHREX-GMBH |
62%
|
of coverage, including filing newer, more targeted patent applications as older patents near expiration. Manufacturing and Supply We do not own or operate manufacturing facilities for the production … |
